FindTrial
Sign In

To find the effect of an Ayurvedic drug, Gokshuradi Guggulu in levels of urine microalbumin in patients with Type 2 diabetes mellitus

EFFECT OF GOKSHURADI GUGGULU IN MICROALBUMINURIA ASSOCIATED WITH TYPE 2 DIABETES MELLITUS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/06/034091
Enrollment
23
Registered
2021-06-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E112- Type 2 diabetes mellitus with kidney complications

Interventions

Intervention1: GOKSHURADI GUGGULU: Gokshuradi guggulu , a gutika formulation, in a dosage of 2 tablets, 500 mg each, thrice daily, half an hour before food with lukewarm water. Control Intervention1:

Sponsors

Dr R Rajam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Known Type 2 diabetes mellitus patients of age group 35-65 years with urine albumin in the range of 30-299 mg in 24-hour urine sample

Exclusion criteria

Exclusion criteria: 1. Patients undergoing treatment with ACE-inhibitors and ARBs. 2. Patients with uncontrolled hypertension 3. Serum creatinine more than 2.5 mg/dl 4. Patients with chronic and severe complications of Diabetes mellitus 5. Patients with history of coronary artery disease and persistent urinary tract infections 6. Patients with other systemic illness 7. Pregnancy and lactation

Design outcomes

Primary

MeasureTime frame
Urine microalbuminTimepoint: Urine microalbumin on 31st day of clinical trial—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Soumya R

Government Ayurveda College, Thiruvananthapuram

draswathyavc@gmail.com9495551057

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026